Products & Services · Total revenues
Otezla — Total revenues
Amgen Otezla — Total revenues decreased by 31.0% to $431.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $437.00M to $431.00M. Over 3 years (FY 2022 to FY 2025), Otezla — Total revenues shows relatively stable performance with a -0.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2020
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market adoption or successful commercial execution, while a decrease may signal increased competition or patent expiration.
Detailed definition
This represents the total gross sales generated by a specific pharmaceutical product line within the company's portfolio...
Peer comparison
Comparable to product-level revenue reporting in other major biopharmaceutical companies.
Metric ID:
amgn_segment_otezla_total_revenuesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $534.00M | $609.00M | $451.00M | $594.00M | $627.00M | $616.00M | $392.00M | $600.00M | $567.00M | $629.00M | $394.00M | $544.00M | $564.00M | $624.00M | $437.00M | $618.00M | $585.00M | $625.00M | $431.00M |
| QoQ Change | — | +14.0% | -25.9% | +31.7% | +5.6% | -1.8% | -36.4% | +53.1% | -5.5% | +10.9% | -37.4% | +38.1% | +3.7% | +10.6% | -30.0% | +41.4% | -5.3% | +6.8% | -31.0% |
| YoY Change | — | — | — | +11.2% | +3.0% | — | -13.1% | +1.0% | -9.6% | +2.1% | +0.5% | -9.3% | -0.5% | -0.8% | +10.9% | +13.6% | +3.7% | +0.2% | -1.4% |
Range$392.00M – $629.00M
CAGR-4.7%
Avg YoY Growth+0.8%
Median YoY Growth+0.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's otezla — total revenues?
- Amgen (AMGN) reported otezla — total revenues of $431.00M in Q1 2026.
- How has Amgen's otezla — total revenues changed year-over-year?
- Amgen's otezla — total revenues decreased by 1.4% year-over-year, from $437.00M to $431.00M.
- What is the long-term trend for Amgen's otezla — total revenues?
- Over 3 years (2022 to 2025), Amgen's otezla — total revenues has grown at a -0.3% compound annual growth rate (CAGR), from $2.29B to $2.27B.
- What does otezla — total revenues mean?
- The total amount of money earned from sales of a specific drug product.